VIRTUSA CORPORATION (NASDAQ:VRTU) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On July25, 2018, Virtusa Corporation (the “Company”) entered into amended and restated executive agreements (“Executive Agreements”), approved by the Compensation Committee and the Board of Directors of the Company, with each of Mr.Kris Canekeratne, the Company’s chairman and chief executive officer, Mr.Samir Dhir, the Company’s president, Mr.Ranjan Kalia, the Company’s executive vice president and chief financial officer, secretary and treasurer, Mr.Thomas R. Holler, the Company’s executive vice president and chief strategy officer, Mr.Keith Modder, the Company’s executive vice president and chief operating officer and Mr.Sundar Narayanan, the Company’s executive vice president and chief people officer. The employment agreements amend and restate the terms of the existing executive agreements entered into in April2007 for Messrs.Canekeratne, Holler and Modder, July2009 for Mr.Kalia in connection with his promotion in fiscal 2009, and August2017 for Mr.Dhir in connection with his appointment as president of Virtusa. The Company entered into Executive Agreements with these executive officers to, among other things, make certain modifications to the severance and change in control arrangements contained in the Executive Agreements (“Severance Benefits”) that are designed to enhance alignment of the Severance Benefits with market practice.
The following is a brief summary of the Severance Benefits contained in the Executive Agreements for the executive officers listed above, including changes from the prior agreements, which are qualified in their entirety by reference to the full text of the Executive Agreements, which are filed as exhibits to this Form8-K and incorporated by reference herein.
· Changed period for continuation of health care benefits from 12 months to 18 months for our CEO and from 6 months to 12 months for these other executive officers; and
· Included payout of current year bonus based on actual performance (prorated).
In connection with, and as part of the Executive Agreements as an exhibit thereto, each of the executive officers listed above also entered into an Employee Non-Competition, Nondisclosure, Non-Solicitation and Developments Agreement, which among other provisions, provides for certain non-competition and non-solicitation of customer and employee restrictions for a period of 12 months following any termination of employment, in addition to other customary terms, including provisions covering non-disclosure obligations and assignment of inventions covenants.